36
Discover us

11 December 2024

We are glad to announce that the entire collection of high-quality molecules offered for free on opnMe.com is also now part of the open access collection of Compounds Australia. Through Compounds Australia, all opnMe molecules can now be accessed in flexible assay-ready formats by drug discovery researchers across Australia and around the world.

60
Discover us

10 December 2024

Meet us at the British Pharmacological Society’s (BPS) Pharmacology 2024 conference and learn how opnMe fosters academic innovation by sharing free molecules by providing collaborative funding opportunities via defined crowdsourcing questions.

62
Discover us

05 December 2024

opnMe has won the 2024 Best Practice Award at the 11th Annual World Open Innovation Conference (WOIC) at the University of California in Berkeley. Explore the full article and learn more about WOIC and how opnMe stood out.

42
Discover us

4 December 2024

In a recent interview with Heping Xu and Mei Chen, Professors at the Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry and Biomedical Sciences at Queen’s University Belfast, we had the opportunity to gain valuable insights into their collaboration with Boehringer Ingelheim and how opnMe has advanced their research in retinal disease.

68
Discover us

25 November 2024

Watch the recorded session of our opnMe online seminar from November 14, 2024, to discover how the selective Cathepsin C (CatC) inhibitor, BI-9740, from opnMe has helped elucidate new roles of CatC signaling in immune response and cardiovascular disease.

Discover us

Hear from our collaborators

slide 1 to 2 of 13